Heart Failure in Clinical Practice
Michael Y. Henein
Format: PDF / Kindle (mobi) / ePub
Heart Failure in Clinical Practice provides a toolkit for clinicians to guide them in the diagnosis and treatment of patients with suspected heart failure. Algorithms and flow diagrams are included to give the reader an illustrated snapshot of the decisions involved in the management of these patients.
effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361:1077-1083.PubMed 88. Paolisso G, Balbi V, Gambardella A, et al. Lisinopril administration improves insulin action in aged patients with hypertension. J Hum Hypertens. 1995;9:541-546.PubMed 89. Yusuf S, Gerstein H, Hoogwerf B, et al.; for the HOPE Study Investigators. Ramipril and the development of diabetes. JAMA. 2001;286:1882-1885. 90. Elliott WJ, Meyer PM. Incident diabetes in
patient to ionizing radiation, a comprehensive cardiac study can be performed in 30–45 min, depending on clinical problem and scanner capabilities. A typical cardiac exam consists of anatomical images for gross anatomy and cine images for the evaluation of ventricular function. Depending on the clinical problem, a number of additional techniques can be added. Using chelated gadolinium contrast agents, first pass myocardial perfusion can be analyzed during pharmacological stress for the diagnosis
CMR study can also reveal coronary artery disease as the underlying cause of ventricular dysfunction prior to angiography. The two main indications for CMR perfusion is presently the evaluation of microvascular obstruction after myocardial infarction and the detection of ischemia in suspected coronary disease.6 13.5 Dilated Cardiomyopathy Dilated cardiomyopathy (DCM) is characterized by uni- or biventricular dilatation, impaired systolic function (Fig. 13.2) and normal coronary lumens on
systemic effects hypotonic hyponatremia neurohormonal activation renal dysfunction AF. See Atrial fibrillation Aging, cardiovascular system drug treatment effects myocytes Angiotensin converting enzyme (ACE) and beta blockers CHF treatment exercise tolerance neurohormonal inhibition RAAS activation stress hemodynamic variables treatment Angiotensin receptor blockers (ARB) and ACEI CHF therapy chronic MR loop diuretic therapy losartan neurohormonal inhibition
complexity of CHF pathophysiology and modern therapy starting to adopt to tailored treatment strategies of specific aspects in patients subgroups a broader and more differentiated perspective on the patients might be required with. 8.1 Introduction Our understanding of the pathophysiology of chronic heart failure (CHF) has significantly advanced over the last 15 years from the historic haemodynamic model of mere pumping failure to a much more complex approach including multiple body systems.